For research use only. We do not sell to patients.
HPK1-IN-19
CAS No. : 2227609-33-6
Biological Activity：HPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2018102366A1 compound I-47.
Research Area：Cancer|Inflammation/Immunology
Targets：MAP4K
Related Small Molecules:HPK1-IN-30;HPK1-IN-25;HPK1-IN-18;GNE-495;HPK1-IN-3;HPK1-IN-20;KY-05009;HPK1-IN-24;HPK1-IN-10;NCB-0846;HPK1-IN-11;HPK1-IN-9;SS47;HPK1-IN-26;HPK1-IN-7;HPK1-IN-29;HPK1-IN-14;HPK1-IN-28;TAK1/MAP4K2 inhibitor 1;FLT3/ITD-IN-4;HPK1-IN-17;DB1113;DMX-5804;MAP4K4-IN-3;GNE 220;RET-IN-19;HPK1-IN-27;TL4-12;HPK1-IN-12
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
